Results of effectiveness trials of PRO 2000 gel: lessons for future microbicide trials.
Abdool Karim
Salim S
SS
D017954:Africa South of the Sahara; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D009282:Naphthalenesulfonates / Q000009:adverse effects* / Q000627:therapeutic use*; D011108:Polymers / Q000009:adverse effects* / Q000627:therapeutic use*; D016896:Treatment Outcome; D014622:Vaginal Creams, Foams, and Jellies / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D009282:Naphthalenesulfonates; C120231:PRO 2000; D011108:Polymers; D014622:Vaginal Creams, Foams, and Jellies